Short Interest in Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Declines By 51.1%

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) was the recipient of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 50,500 shares, a drop of 51.1% from the February 28th total of 103,300 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 609,700 shares, the short-interest ratio is presently 0.1 days.

Reckitt Benckiser Group Price Performance

OTCMKTS:RBGLY traded up $0.20 during mid-day trading on Friday, hitting $13.56. 183,173 shares of the company’s stock were exchanged, compared to its average volume of 336,059. Reckitt Benckiser Group has a one year low of $10.24 and a one year high of $14.10. The business has a fifty day moving average price of $13.26 and a 200 day moving average price of $12.60. The company has a current ratio of 0.69, a quick ratio of 0.47 and a debt-to-equity ratio of 0.97.

Reckitt Benckiser Group Increases Dividend

The business also recently declared a dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 11th will be paid a $0.2909 dividend. The ex-dividend date is Friday, April 11th. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.19.

Wall Street Analyst Weigh In

RBGLY has been the topic of a number of research reports. Royal Bank of Canada reaffirmed an “outperform” rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. HSBC raised Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Hsbc Global Res raised Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, December 11th. Finally, Barclays lowered Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.